Literature DB >> 8804040

The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific.

S Lovestone1, B H Anderton, C Hartley, T G Jensen, A L Jorgensen.   

Abstract

The apolipoprotein E (apoE) gene has been identified as a susceptibility gene for Alzheimer's disease, although the mechanism whereby apoE exerts this effect has not been determined. The aim of this study was to examine the intracellular fate of apoE and we demonstrate that in mammalian cells-transiently expressing tau and the low density lipoprotein receptor, apoE is taken up from cerebrospinal fluid (CSF) and apoE3, but not apoE4, reaches the cytoplasm. This isoform difference in the intracellular distribution of apoE is dependent upon tau expression and, although tau phosphorylation was not affected by apoE, these results suggest that apoE interactions with the cytoskeleton might be important in the molecular pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804040     DOI: 10.1097/00001756-199604100-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons.

Authors:  Y Huang; X Q Liu; T Wyss-Coray; W J Brecht; D A Sanan; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

2.  Role of glycosaminoglycans in determining the helicity of paired helical filaments.

Authors:  M Arrasate; M Pérez; J M Valpuesta; J Avila
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.

Authors:  A Salehi; E J Dubelaar; M Mulder; D F Swaab
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 4.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic.

Authors:  R B DeMattos; F E Thorngate; D L Williams
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

7.  Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.

Authors:  Luke Whiley; Arundhuti Sen; James Heaton; Petroula Proitsi; Diego García-Gómez; Rufina Leung; Norman Smith; Madhav Thambisetty; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Cristina Legido-Quigley
Journal:  Neurobiol Aging       Date:  2013-09-13       Impact factor: 4.673

Review 8.  Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.

Authors:  Yadong Huang; Karl H Weisgraber; Lennart Mucke; Robert W Mahley
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease.

Authors:  S Lovestone
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

10.  Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells.

Authors:  Toshiyuki Nakamura; Atsushi Watanabe; Takahiro Fujino; Takashi Hosono; Makoto Michikawa
Journal:  Mol Neurodegener       Date:  2009-08-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.